Hiroko Masamune
2018
In 2018, Hiroko Masamune earned a total compensation of $992.9K as Chief Development Officer at Viking Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $106,000 |
|---|---|
| Option Awards | $395,348 |
| Salary | $302,726 |
| Stock Awards | $188,850 |
| Total | $992,924 |
Masamune received $395.3K in option awards, accounting for 40% of the total pay in 2018.
Masamune also received $106K in non-equity incentive plan, $302.7K in salary and $188.9K in stock awards.
Rankings
In 2018, Hiroko Masamune's compensation ranked 9,229th out of 14,244 executives tracked by ExecPay. In other words, Masamune earned more than 35.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,229 out of 14,244 | 35th |
Division Manufacturing | 3,690 out of 5,759 | 36th |
Major group Chemicals And Allied Products | 1,388 out of 2,122 | 35th |
Industry group Drugs | 1,166 out of 1,811 | 36th |
Industry Pharmaceutical Preparations | 905 out of 1,385 | 35th |
Source: SEC filing on April 5, 2019.
Masamune's colleagues
We found two more compensation records of executives who worked with Hiroko Masamune at Viking Therapeutics in 2018.